Concepedia
Statistics
Publications
5
Citations
183
H-Index
Active since
2020
Affiliations
Université Paris Cité(Current)
Inserm
Université de Lorraine
Pitié-Salpêtrière Hospital
Université de Rouen Normandie
Anaïs Andrillon is an author at Université Paris Cité specializing in uveal disease, immunology, and pharmacotherapy.
Publications per year
2020–2023
Anti–Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema
Mathilde Leclercq, Anaïs Andrillon, Georgina Maalouf et al. · Ophthalmology · 2021 · 76 citations · Full text
Medicine, Ophthalmology, Pharmacotherapy +12
Performance of propensity score matching to estimate causal effects in small samples
Anaïs Andrillon, Romain Pirracchio, Sylvie Chevret · Statistical Methods in Medical Research · 2020 · 44 citations
Public Health, Biostatistics, Causal Inference +16
Lower Relapses Rate With Infliximab Versus Adalimumab in Sight-Threatening Uveitis: A Multicenter Study of 330 Patients
Georgina Maalouf, Anaïs Andrillon, Mathilde Leclercq et al. · American Journal of Ophthalmology · 2022 · 26 citations · Full text
Medicine, Immunology, Pharmacotherapy +17
Mogamulizumab induces long‐term immune restoration and reshapes tumour heterogeneity in Sézary syndrome*
Marie Roelens, Adèle de Masson, Anaïs Andrillon et al. · British Journal of Dermatology · 2022 · 24 citations
Life Sciences, Immunology, Oncology +17
Incorporating patient-reported outcomes in dose-finding clinical trials with continuous patient enrollment
Anaïs Andrillon, Lucie Biard, Shing M. Lee · Journal of Biopharmaceutical Statistics · 2023 · 13 citations · Full text
Medicine, Oncology, Cancer Drug Toxicity Management +16
1–5 of 5